- Home
- Publications
- Publication Search
- Publication Details
Title
Development of Passive Immunotherapies for Synucleinopathies
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 31, Issue 2, Pages 203-213
Publisher
Wiley
Online
2015-12-25
DOI
10.1002/mds.26481
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease brain
- (2015) Rosalind F. Roberts et al. BRAIN
- Behavioural deficits in transgenic mice expressing human truncated (1–120 amino acid) alpha-synuclein
- (2015) Katie Hall et al. EXPERIMENTAL NEUROLOGY
- Extracellular α-synuclein alters synaptic transmission in brain neurons by perforating the neuronal plasma membrane
- (2015) Carla R. Pacheco et al. JOURNAL OF NEUROCHEMISTRY
- Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson’s Disease
- (2015) Qing He et al. MOLECULAR NEUROBIOLOGY
- Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy
- (2015) Markus Mandler et al. Molecular Neurodegeneration
- α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
- (2015) W. Peelaerts et al. NATURE
- Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study
- (2015) Niels Kruse et al. NEUROBIOLOGY OF AGING
- Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology
- (2015) Nishant N. Vaikath et al. NEUROBIOLOGY OF DISEASE
- The relation between α-synuclein and microglia in Parkinson’s disease: Recent developments
- (2015) V. Sanchez-Guajardo et al. NEUROSCIENCE
- Low alpha-synuclein levels in the blood are associated with insulin resistance
- (2015) Gerardo Rodriguez-Araujo et al. Scientific Reports
- Normalization of Overexpressed α-Synuclein Causing Parkinson's Disease By a Moderate Gene Silencing With RNA Interference
- (2015) Masaki Takahashi et al. Molecular Therapy-Nucleic Acids
- Anti-Human α-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-α-Synuclein Rat Model of Parkinson’s Disease
- (2015) Md Shahaduzzaman et al. PLoS One
- Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review
- (2014) N. Malek et al. ACTA NEUROLOGICA SCANDINAVICA
- Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials
- (2014) Markus Mandler et al. ACTA NEUROPATHOLOGICA
- Synucleins Regulate the Kinetics of Synaptic Vesicle Endocytosis
- (2014) K. J. Vargas et al. JOURNAL OF NEUROSCIENCE
- Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models
- (2014) D. Games et al. JOURNAL OF NEUROSCIENCE
- ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo
- (2014) Brian Spencer et al. MOLECULAR THERAPY
- Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice
- (2014) Veronica Lindström et al. NEUROBIOLOGY OF DISEASE
- Towards translational therapies for multiple system atrophy
- (2014) Daniela Kuzdas-Wood et al. PROGRESS IN NEUROBIOLOGY
- Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry
- (2014) John F. Kellie et al. Scientific Reports
- Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
- (2014) Oskar Hansson et al. Alzheimers Research & Therapy
- Alpha-synuclein biology in Lewy body diseases
- (2014) Woojin Scott Kim et al. Alzheimers Research & Therapy
- α-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded α-Synuclein and Neurodegeneration
- (2014) Hien T. Tran et al. Cell Reports
- Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation
- (2014) Diana F. Lázaro et al. PLoS Genetics
- A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats
- (2013) Silke Nuber et al. BRAIN
- The N-terminus of α-synuclein is essential for both monomeric and oligomeric interactions with membranes
- (2013) Nikolai Lorenzen et al. FEBS LETTERS
- The Function of α-Synuclein
- (2013) Jacob T. Bendor et al. NEURON
- Rasagiline Ameliorates Olfactory Deficits in an Alpha-Synuclein Mouse Model of Parkinson's Disease
- (2013) Géraldine H. Petit et al. PLoS One
- Structural and functional characterization of two alpha-synuclein strains
- (2013) Luc Bousset et al. Nature Communications
- The genetics and neuropathology of Parkinson’s disease
- (2012) Henry Houlden et al. ACTA NEUROPATHOLOGICA
- From α-synuclein to synaptic dysfunctions: New insights into the pathophysiology of Parkinson's disease
- (2012) Arianna Bellucci et al. BRAIN RESEARCH
- Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies
- (2012) Kostas Vekrellis et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease
- (2012) Min Jeong Park et al. Journal of Clinical Neurology
- Antibody-Aided Clearance of Extracellular -Synuclein Prevents Cell-to-Cell Aggregate Transmission
- (2012) E.-J. Bae et al. JOURNAL OF NEUROSCIENCE
- The generic amyloid formation inhibition effect of a designed small aromatic β-breaking peptide
- (2011) Anat Frydman-Marom et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Alpha-synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease
- (2011) Arianna Bellucci et al. BRAIN RESEARCH
- α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
- (2011) Christian Hansen et al. JOURNAL OF CLINICAL INVESTIGATION
- Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
- (2011) Laura A. Volpicelli-Daley et al. NEURON
- Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
- (2011) Eliezer Masliah et al. PLoS One
- Antibodies against Alpha-Synuclein Reduce Oligomerization in Living Cells
- (2011) Thomas Näsström et al. PLoS One
- Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology
- (2010) Ayse Ulusoy et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease
- (2010) Jia-Yi Li et al. MOVEMENT DISORDERS
- Lewy body pathology in fetal grafts
- (2009) Yaping Chu et al. Annals of the New York Academy of Sciences
- Structural Reorganization of α-Synuclein at Low pH Observed by NMR and REMD Simulations
- (2009) Kuen-Phon Wu et al. JOURNAL OF MOLECULAR BIOLOGY
- Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
- (2008) Jia-Yi Li et al. NATURE MEDICINE
- Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood
- (2008) Robin Barbour et al. Neurodegenerative Diseases
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started